Aug 19, 2025 • Benzinga
SOMEWHAT-BULLISH
Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy - Teleflex ( NYSE:TFX )
Innovative hyaluronic acid technology delivers enhanced control and precision, significantly lowering the risk of rectal toxicity during prostate radiation treatment.1-4 Initial cases have now been performed in Japan.
Aug 19, 2025 • GlobeNewswire
NEUTRAL
Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy
Innovative hyaluronic acid technology delivers enhanced control and precision, significantly lowering the risk of rectal toxicity during prostate radiation treatment.1-4Initial cases have now been performed in Japan.
Aug 12, 2025 • Zacks Commentary
BULLISH
Should Value Investors Buy Teleflex ( TFX ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Aug 06, 2025 • Zacks Commentary
BULLISH
TFX vs. SONVY: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Teleflex ( TFX Quick QuoteTFX - ) and SONOVA HOLDING ( SONVY Quick QuoteSONVY - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
Aug 06, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Is Tactile Systems Technology ( TCMD ) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Jul 31, 2025 • Zacks Commentary
NEUTRAL
Teleflex ( TFX ) Q2 Earnings and Revenues Top Estimates
Teleflex (TFX) delivered earnings and revenue surprises of +11.01% and +1.27%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?